Brochures

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

EDOF FAQ

FAQ eDOF 21Dec2017

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc

CheckMATE Implants IFU

4001-2100_Rev-D_CheckMate_Plate

Femoral Condyle Implants IFU

2001-2000_Rev-K-Knee

Femoral Condyle Instrument IFU

CheckMATE Screws & Instruments IFU

4001-2110_rev-B_CheckMate_Screw

PF Wave IFU – Trochelar Implants

PF Classic IFU – Implants

2001-2100_Rev-H-Patello-Femoral

PF Classic IFU – Instruments

ToeMotion IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

PF Wave IFU – Patellar Implants

Toe HemiCAP IFU – Instruments

UniCAP IFU – Instruments

Shoulder IFU – Instruments (All Except OVO & OVOMotion)

UniCAP Small IFU – Implants

K001-2002_Rev-E-UniSmall

Wrist Hemi IFU – Implants

3W01-1000_Rev-C_WristMotion

Glenoid IFU

3001-2010_Rev-F_Glenoid

Shoulder IFU – Implants (OVO)

3001-2020-Rev-H-OVO

Glenojet Implant IFU

3001-2012 Rev E_Glenojet IFU

ToeMATE IFU

4001-2007_REV D_eng

Wrist IFU – Instruments

0020-0013_Rev D-Reusable Instrument Sets_11 Langs

OVO with Inlay Glenoid Shoulder Arthroplasty Technique Guide

OVO:Glenoid Tech Guide_Rev D_3001-3009

Glenojet Instrument IFU

3001-2011_REV-B-Glenojet_eng

Wave Kahuna IFU – Patello-Femoral Implant

Regular Cycle Instrument IFU – OVO, OVOMotion & Kahuna

0020-0016_rev-C-Instruments_4min

SpiralUP TCL IFU – Instrument

4001-2012_rev-B_IFU_SpiralUp_TCL_Instruments

BOSS Toe Fixation System IFU

4001-2011_Rev-A_Boss

SpeedSpiral CMC – Instrument

3001-2015_Rev-A_SpeedSpiral CMC_Instruments

Wave Kahuna IFU – Patella Implant

SpeedSpiral CMC Implant IFU

SpeedSpiral CMC- Implant IFU

Total Wrist IFU – Implants

Shoulder IFU – Implants (OVOMotion)

3001-2023_Rev_B_OVOMotion

PF Wave IFU- Instruments

EDOF FAQ

FAQ eDOF 21Dec2017

Toe Clinical Survey Outcomes

ClinicalSurvey_Toe_Rev B

Shoulder IFU – Implants (25-40)

UniCAP IFU – Implants

Toe HemiCAP IFU – DF Implants (CAP + Screw)

Toe HemiCAP IFU – 7mm Screw

ToeMotion IFU – Implants

Arthrosurface Stemless Shoulder Arthroplasty Hits 10 Year Mark!

18-Nov-2013

FRANKLIN, Mass., Nov. 18, 2013 /PRNewswire/ — Arthrosurface Incorporated (arthrosurface.com), a developer of less-invasive joint restoration and resurfacing systems, performed its first US stemless shoulder resurfacing in 2003. The Company continued to expand the technology and introduced the stemless total shoulder system in 2011 using the world’s first aspherical humeral implant combined with an off-axis inlay glenoid. Other Orthopaedic companies have only recently started to explore stemless total shoulder designs. However, these designs still require removal of the humeral head and implantation of spherically shaped implants that are not anatomic by design.

(Logo: http://photos.prnewswire.com/prnh/20131118/NE19554LOGO)

Steve Ek, CEO commented; “We realized 10 years ago that the traditional stemmed shoulder arthroplasty presented unnecessary technical challenges to surgeons while attempting to accurately restore the humeral head position in space. In addition, we pioneered the concept of aspherical geometries to restore humeral head anatomy. The combination of a stemless design and the aspherical head geometries is what makes the Arthrosurface shoulder uniquely anatomical and is a cornerstone of our intellectual property in the shoulder portfolio.”

Several years ago, Arthrosurface took its innovation to the other side of the shoulder joint and introduced the first humeral head preserving inlay glenoid. “To maintain bone stock during shoulder arthroplasty, it is necessary to preserve the head and restore the glenoid surface to its normal height. By using an inlay glenoid and a special off-axis preparation system, Arthrosurface is the first company in the world that has designed a stemless total shoulder that can be performed without resection of the humeral head,” said Dr. Matthias Schurhoff, VP of Clinical Affairs.

Combining the three innovations of stemless design, aspherical head geometry and inlay glenoid implantation are unique in the industry.  Simply eliminating the stem only addresses one part of the equation and therefore does not provide an anatomic shoulder restoration.

“For over two years, I have used HemiCAP® shoulder resurfacing combined with the inlay glenoid as an alternative to stemmed total shoulder arthroplasty. In my experience, no procedure has been as rewarding for both the patient and the surgeon,” says Dr. John Uribe, Chairman, Dept. of Orthopedic Surgery, FIU School of Medicine, Head Team Physician, Miami Dolphins and Florida Panthers.

Arthrosurface reports that it is the only company to offer a full range of shoulder resurfacing implants that match both the size of the defect and the anatomical curves of the patient’s humeral head providing individual solutions from focal to total shoulder arthroplasty.

­About Arthrosurface

Arthrosurface Incorporated is an emerging leader in the design and distribution of orthopedic devices for joint preservation, restoration and resurfacing. The Company’s proprietary HemiCAP® system is a unique, less invasive technology that can be used to treat a wide variety of joint conditions caused by trauma, injury and disease. Arthrosurface has developed a broad portfolio of implantable devices and surgical instruments with FDA clearance for the shoulder, knee, toe and hip. Founded in 2002 and based in Franklin, MA, Arthrosurface markets and distributes its products in the United States and more than twenty other countries around the globe. To date, over 50,000 patients have been treated by more than 4,700 surgeons worldwide. For additional information, please visit arthrosurface.com.

For inquiries please contact:
Francis J. Fedorowicz, Jr.
Executive Vice President
Arthrosurface Incorporated
Telephone: 508-520-3003
Email: ffedorowicz@arthrosurface.com

SOURCE Arthrosurface Incorporated

RELATED LINKS
https://www.arthrosurface.com

What can Arthrosurface do for YOU?

Are you looking for a less invasive procedure to help eliminate joint pain, and are too active for a total joint replacement?  The video below showcases some Arthrosurface HemiCAP patients getting their active lifestyles back!  Could this be right for you?

[youtube https://www.youtube.com/watch?v=YjUgJ96AtbU&w=560&h=315]

If you are an Arthrosurface HemiCAP Patient and are back to the activities you love, we invite you to share your story by participating in our Patient Testimonial Program.  Please contact Aislyn Arnone at movefreely@arthrosurface.com for more information.  

30,000 Patients and 100+ Publications

(PR Newswire) – November 28, 2011 – Arthrosurface, Inc. (arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has recently surpassed the 30,000 patient implantation milestone with products having been implanted in Shoulder, Knee, Hip, Toe and Ankle during the last 7 years. The Arthrosurface technology is now available in all 50 states and in more than 25 countries worldwide. In addition to reaching this significant patient milestone a recent global literature review revealed over 100 sources referencing the Arthrosurface HemiCAP® implants.

Arthrosurface began selling shoulder implants for localized arthritis in the US in 2004 and focal knee implants internationally in 2005. Since then, new products have been added each year to expand its growing list of indications that now number 10 product families with over 150 different implant configurations. While the company believed that its technology would one day become a new standard of care, it also realized that it would eventually require data to support and validate its technology in the conservative orthopaedic marketplace.

Dr. Matthias Schurhoff, MD, VP of Clinical Operations and Scientific Affairs at Arthrosurface, recently commented “We just completed a new worldwide search for all clinical research and related publications on the Arthrosurface technology and the results continue to be extremely positive: Over 100 documented references underline the growing interest for patient specific joint solutions. More than 200 authors and experts in the field of cartilage repair have commented, reported or assessed HemiCAP® resurfacing in over 60 peer reviewed publications.”

The growing body of evidence shows that the positive basic science data is supported by clinical outcomes across the different product groups. The next phase of clinical publications will focus on outcome studies ranging from two to seven years follow-up. At the same time, Arthrosurface is planning to introduce a mix of competitive, new technologies to further complement the surgical spectrum of joint arthrosis and arthritis.”

As people live longer, Arthrosurface believes that there is an increasing need for an interim solution prior to total joint surgery. A recent study conducted at Brigham and Women’s Hospital, Boston concluded that arthritis is now affecting people earlier in life. The researchers used a validated computer simulation model, called OAPol, to track the number of new knee osteoarthritis cases in the United States in the 1990s and 2010s. They calculated that 7% of Americans older than 45 years have osteoarthritis. The mean age of a patient with osteoarthritis has shifted from 72 years in the 1990s to 56 years today, an average of 16 years earlier in life. The investigators predict 6.5 million new cases of knee osteoarthritis between the ages of 35 to 84 years in the next 10 years. Of those cases, 59% will be in the 45 to 64 year-old age group which is also the fastest growing segment of the overall population based on the recent census.

Arthrosurface boasts that it is perfectly positioned to serve this growing trend in joint disease. With its Focal-to-Total Joint Platform Technology, it offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the joint contour of each patient.

Contact:

Arthrosurface, Inc
28 Forge Parkway
Franklin, MA  02038
508-520-3003

Arthrosurface featured on CNN

18-Jul-2011

Arthrosurface^® was recently featured on CNN during primetime as a new device technology for people suffering from post-traumatic degenerative joint disease and avascular necrosis. These conditions may lead to early joint replacement. Joint replacement devices were conceived and usually indicated for patients over 65 years old. The Arthrosurface^® HemiCAP^® system is discussed as another possible solution for the younger and middle aged patient population. It is a surgical treatment that places a “CAP” device into the joint surface thereby replacing the damaged cartilage and bone. It is sometimes described as a “patch” similar to the way a pothole may be repaired in the road. The HemiCAP^® implant recreates a new smooth, slippery and congruent joint surface.

Discovery Health channel is running the news segment as part of the new Healthcare coverage.

CNN feature

[youtube=https://www.youtube.com/watch?v=5ILQ2yYcMS0]

Discovery Health

[youtube=https://www.youtube.com/watch?v=HaEHklZ1Crk]

Jacksonville surgeon offers an option to total joint replacement

15-Jul-2011

Television interview of Dr. Stanton Longenecker of the Jacksonville Orthopaedic Institute performing an Arthrosurface knee resurfacing procedure. Dr Longenecker describes the procedure as “filling a pothole rather than tearing up the entire road”.  Also a patient is interviewed who is back to surfing just 2 months after surgery.

Dr. Robert Buonanno Channel 10 interview

15-Jul-2011

Dr. Robert Buonanno was interviewed by Channel 10 WJAR in Rhode Island for his treatment of a patient with the Arthrosurface^®Femoral Condyle system.  Dr. Buonanno is participating in the US clinical trial** of this device.  His patient is now over 2 1/2 years post operative and doing great.

https://www.youtube.com/watch?v=l-4gqPReNEc